Geneos Wealth Management’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$139K Buy
1,248
+185
+17% +$21.2K ﹤0.01% 1076
2025
Q4
$119K Hold
1,063
﹤0.01% 1095
2025
Q3
$116K Buy
1,063
+426
+67% +$44.7K ﹤0.01% 1075
2025
Q2
$64.2K Sell
637
-18,874
-97% -$1.77M ﹤0.01% 1443
2025
Q1
$1.8M Buy
19,511
+7,679
+65% +$748K 0.03% 516
2024
Q4
$1.15M Sell
11,832
-6,261
-35% -$615K 0.04% 387
2024
Q3
$1.72M Sell
18,093
-370
-2% -$34K 0.07% 307
2024
Q2
$1.67M Sell
18,463
-9,089
-33% -$803K 0.07% 281
2024
Q1
$2.47M Sell
27,552
-2,303
-8% -$194K 0.11% 217
2023
Q4
$2.43M Sell
29,855
-3,450
-10% -$261K 0.12% 202
2023
Q3
$2.44M Buy
33,305
+440
+1% +$33.4K 0.13% 185
2023
Q2
$2.47M Buy
32,865
+196
+0.6% +$14K 0.13% 181
2023
Q1
$2.32M Buy
+32,669
New +$2.31M 0.14% 174

Other funds holding AVUS

Geneos Wealth Management's AVUS Position: Q1 2026 in Review

Geneos Wealth Management increased its Avantis US Equity ETF (AVUS) stake by 17% in Q1 2026, buying an estimated $21.2K and bringing the position to 1,248 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

Geneos Wealth Management first reported a position in AVUS in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.47M in Q2 2023. 553 funds tracked by Wall St. Rank hold AVUS as of Q1 2026.

  • Geneos Wealth Management held 1,248 shares of Avantis US Equity ETF worth $139K as of Q1 2026.
  • Geneos Wealth Management bought 185 Avantis US Equity ETF shares in Q1 2026, an estimated $21.2K.
  • Avantis US Equity ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1076 holding.
  • Geneos Wealth Management first reported a position in Avantis US Equity ETF in Q1 2023 and has held it in 13 quarters since.
  • Geneos Wealth Management's Avantis US Equity ETF position peaked at $2.47M in Q2 2023.
  • 553 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.